CeloNova Biosciences Receives FDA Approval of COBRA PzF™ Stent System

08:00 EST 1 Mar 2017 | Businesswire

This article has expired, however you can still download the PDF.
Nano-Coated Stent Provides Excellent Safety Profile, Very Low Restenosis and Short 30 Day Dual Antiplatelet Therapy (DAPT) Regimen CeloNova BioSciences, Inc. (CeloNova) today announced that it has received U.S. Food and Drug...

Other Sources for this Article

For CeloNova BioSciences, Inc.
Jessica Volchok, 310-849-7985


More From BioPortfolio on "CeloNova Biosciences Receives FDA Approval of COBRA PzF™ Stent System"

Quick Search


Relevant Topics

Acute Coronary Syndromes ACS
Acute Coronary Syndromes (ACS) is an umbrella term for situations where the blood supplied to the heart muscle is suddenly blocked. Treatment for acute coronary syndrome includes medicines and a procedure known as angioplasty, during which doctors inflat...

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...